Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravesical gentamicin prophylaxis for recurrent urinary tract infection
ACTRN12625000856415Phase 2Active, not recruiting
- Sponsor
- University of Calgary
- Start
- Jul 2024
- Modality
- Implantable Devices → Device-based Delivery → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 2 trial of gentamicin in urinary tract infection (UTI), sponsored by University of Calgary. Started Jul 2024; status: active, not recruiting.
02
Drugs
gentamicin
03
Conditions
urinary tract infection (UTI)
Beyond the preview
Go deeper on ACTRN12625000856415.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12625000856415.